Extrait

This is a randomised, open-label phase II study comparing GEM-P chemotherapy (experimental arm) with CHOP (control arm) in previously untreated T-cell lymphoma. Eligible patients will be randomised 1:1 between 4-weekly GEM-P or 3-weekly CHOP chemotherapy.

Critère d'inclusion

• Peripheral T-cell Lymphoma NOS,Anaplastic large cell lymphoma, ALK-negative,Angioimmunoblastic T-cell Lymphoma,Hepatosplenic Gamma/ Delta T-cell Lymphoma

Liens

• ictrp
• nct